Get started
Author

Valentina Cutano

Observed name: V. Cutano
ORCID: 0000-0001-6235-1082
Observed ORCID: 0000-0001-6235-1082
OpenAlex ID: A5042769748
HDAC7‐mediated control of tumour microenvironment maintains proliferative and stemness competence of human mammary epithelial cells
2019 · Valentina Cutano, Eros Di Giorgio, et al. · Molecular Oncology · 45
PDF
Identification of the Kelch Family Protein Nd1-L as a Novel Molecular Interactor of KRIT1
2012 · Paolo Guazzi, Luca Goitre, et al. · PLoS ONE · 40
PDF
The MEF2–HDAC axis controls proliferation of mammary epithelial cells and acini formation in vitro
2015 · Andrea Clocchiatti, Eros Di Giorgio, et al. · Journal of Cell Science · 33
Mitochondrial Tumor Suppressors—The Energetic Enemies of Tumor Progression
2021 · Pavel Jakoube, Valentina Cutano, et al. · Cancer Research · 13
PDF
The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer
2025 · Valentina Cutano, Ming Li Chia, et al. · npj Breast Cancer · 12
PDF
LACTB induces cancer cell death through the activation of the intrinsic caspase-independent pathway in breast cancer
2022 · Juan M. Gonzalez-Morena, Sara Escudeiro-Lopes, et al. · APOPTOSIS · 10
PDF
LACTB exerts tumor suppressor properties in epithelial ovarian cancer through regulation of Slug
2022 · Valentina Cutano, Jessica Marianne Ferreira Mendes, et al. · Life Science Alliance · 8
PDF
Fluorescence Microscopy Study of Rap1 Subcellular Localization
2013 · Luca Goitre, Valentina Cutano, et al. · Methods in molecular biology · 7
A Regulative Epigenetic Circuit Supervised by HDAC7 Represses IGFBP6 and IGFBP7 Expression to Sustain Mammary Stemness
2021 · Eros Di Giorgio, Valentina Cutano, et al. · Epigenomics · 4
Integrated single-cell analyses of affinity-tested B cells enable the identification of a gene signature to predict antibody affinity
2026 · Michele Chirichella, Matthew Ratcliff, et al. · Cell Systems · 3
HDAC4 controls senescence and aging by safeguarding the epigenetic identity and ensuring the genomic integrity
2020 · Eros Di Giorgio, Harikrishnareddy Paluvai, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
Targeting the Chromatin-Modifying Enzyme, KDM5C, Enhances AKT Inhibition Response in ER+ Breast Cancer
2026 · Valentina Cutano, Shanade Dunn, et al. · Molecular Cancer Therapeutics · 1
KRIT1 and reactive oxygen species: a novel molecular pathway involved in cerebral cavernous malformations
2012 · L. Goitre, M. Villoria-Recio, et al. · Free Radical Biology and Medicine · 1
Supplementary Figure S4 from Targeting the Chromatin-Modifying Enzyme, KDM5C, Enhances AKT Inhibition Response in ER+ Breast Cancer
2026 · Valentina Cutano, Shanade Dunn, et al.
Supplementary Figure S5 from Targeting the Chromatin-Modifying Enzyme, KDM5C, Enhances AKT Inhibition Response in ER+ Breast Cancer
2026 · Valentina Cutano, Shanade Dunn, et al.
Supplementary Data from Targeting the Chromatin-Modifying Enzyme, KDM5C, Enhances AKT Inhibition Response in ER+ Breast Cancer
2026 · Valentina Cutano, Shanade Dunn, et al.
Supplementary Figure S10 from Targeting the Chromatin-Modifying Enzyme, KDM5C, Enhances AKT Inhibition Response in ER+ Breast Cancer
2026 · Valentina Cutano, Shanade Dunn, et al.
Supplementary Table S4 from Targeting the Chromatin-Modifying Enzyme, KDM5C, Enhances AKT Inhibition Response in ER+ Breast Cancer
2026 · Valentina Cutano, Shanade Dunn, et al.
Supplementary Table S1 from Targeting the Chromatin-Modifying Enzyme, KDM5C, Enhances AKT Inhibition Response in ER+ Breast Cancer
2026 · Valentina Cutano, Shanade Dunn, et al.
Supplementary Figure S8 from Targeting the Chromatin-Modifying Enzyme, KDM5C, Enhances AKT Inhibition Response in ER+ Breast Cancer
2026 · Valentina Cutano, Shanade Dunn, et al.
Supplementary Table S2 from Targeting the Chromatin-Modifying Enzyme, KDM5C, Enhances AKT Inhibition Response in ER+ Breast Cancer
2026 · Valentina Cutano, Shanade Dunn, et al.
Supplementary Figure S6 from Targeting the Chromatin-Modifying Enzyme, KDM5C, Enhances AKT Inhibition Response in ER+ Breast Cancer
2026 · Valentina Cutano, Shanade Dunn, et al.
Supplementary Figure S7 from Targeting the Chromatin-Modifying Enzyme, KDM5C, Enhances AKT Inhibition Response in ER+ Breast Cancer
2026 · Valentina Cutano, Shanade Dunn, et al.
Supplementary Figure S2 from Targeting the Chromatin-Modifying Enzyme, KDM5C, Enhances AKT Inhibition Response in ER+ Breast Cancer
2026 · Valentina Cutano, Shanade Dunn, et al.
Supplementary Table S3 from Targeting the Chromatin-Modifying Enzyme, KDM5C, Enhances AKT Inhibition Response in ER+ Breast Cancer
2026 · Valentina Cutano, Shanade Dunn, et al.
Works count: 43
Citation count: 179
H-index: 7
I10-index: 6
Year
Topic
Type